|
Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. PubMed PMID: 34861154.
AÑO: 2022; IF: 44.5
|
34861154
|
Chalkias A, Skoulakis A, Papagiannakis N, Laou E, Tourlakopoulos K, Pagonis A, Michou A, Ntalarizou N, Mermiri M, Ragias D, Bernal-Morell E, Cebreiros Lopez I, Garcia de Guadiana-Romualdo L, Eugen-Olsen J, Gourgoulianis K, Pantazopoulos I; SPARCOL Investigators. Circulating suPAR associates with severity and in-hospital progression of COVID-19. Eur J Clin Invest. 2022 Jul;52(7):e13794. doi: 10.1111/eci.13794. Epub 2022 May 4. PubMed PMID: 35435245; PubMed Central PMCID: PMC9111634.
AÑO: 2022; IF: 5.5
|
|
Haroon MZ, Farooq U, Ashraf S, Zeb S, Gillani SY, Malik S, Ali R, Irshad R, Mehmood Z, Abbas Y, Masood A, Ghafoor A, Khalil AT, Asif H, Khan S, Ujjan ID, Nigar R, Livingstone S, Pascual-Figal DA, Togni S, Allergini P, Riva A, Khan A. Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial. J Physiol Pharmacol. 2022 Jun;73(3). doi: 10.26402/jpp.2022.3.09. Epub 2022 Oct 22. PubMed PMID: 36302537.
AÑO: 2022; IF: 2.2
|
|
Gonzalez-Del-Hoyo M, Rodriguez-Leor O, Cid-Alvarez AB, de Prado AP, Ojeda S, Serrador A, Lopez-Palop R, Martin-Moreiras J, Rumoroso JR, Cequier A, Ibanez B, Cruz-Gonzalez I, Romaguera R, Raposeiras-Roubin S, Moreno R, Rossello X; Working Group on the Infarct Code of the Interventional Cardiology Association of the Spanish Society of Cardiology (Grupo de Trabajo de Codigo Infarto de la Asociacion de Cardiologia Intervencionista de la Sociedad Espanola de Cardiologia). Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort. Int J Cardiol. 2022 Nov 15;367:90-98. doi: 10.1016/j.ijcard.2022.08.036. Epub 2022 Aug 25. PubMed PMID: 36030132.
AÑO: 2022; IF: 3.5
|
|
Aimo A, Pascual-Figal DA, Barison A, Cediel G, Vicente AH, Saccaro LF, Emdin M, Bayes-Genis A. Colchicine for the treatment of coronary artery disease. Trends Cardiovasc Med. 2021 Nov;31(8):497-504. doi: 10.1016/j.tcm.2020.10.007. Epub 2020 Oct 20. PubMed PMID: 33096241.
AÑO: 2021; IF: 8.049
|